- Advertisement -

MicroRNA Biomarkers Make Melanoma Diagnosis More Objective

Melanoma is the least common type of skin cancer but one of the most deadly, and the survival rate for advanced disease is just...

Study Finds Antidepressants May Accelerate Cognitive Decline in Dementia Patients

New research reveals concerning insights into the impact of antidepressants on cognitive decline among dementia patients, suggesting that these widely prescribed medications might exacerbate...

Maia Biotechnology Looks To IPO For Cancer Treatment Development – Seeking Alpha

gorodenkoff/iStock via Getty ImagesA Quick Take On Maia Biotechnology Maia Biotechnology (MAIA) has filed to raise an undisclosed amount in an...

Novartis Commits up to $2.2B Toward Developing Arrowhead siRNA Therapy

Novartis has agreed to license and develop Arrowhead Pharmaceuticals’ preclinical stage small interfering RNA (siRNA) therapy ARO-SNCA, a potential treatment for Parkinson’s disease and...

E-bike incentive programs in North America: New online tracker from Portland...

For governments and clean energy advocates looking to encourage people to use e-bikes for transportation, a new online tool from Portland State University researchers offers an overview of the...

The 2014 Affordable Care Act’s Medicaid expansion had positive spillover effects,...

The 2014 Affordable Care Act’s Medicaid expansion had positive spillover effects, increasing participation in the Supplemental Nutrition Assistance Program (SNAP) by almost 3 percentage points...

CDMOs Expand and Build for Future Growth

The top contract development and manufacturing organizations (CDMOs) have been busy in recent months expanding their service offerings, building new facilities, and navigating how...

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished...

CDMOs Expand and Build for Future Growth

The top contract development and manufacturing organizations (CDMOs) have been busy in recent months expanding their service offerings, building new facilities, and navigating how...

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished...

Thermo and Michael J. Fox Foundation Collaborate to Advance Proteomics-Enabled Parkinson’s Therapy

Thermo Fisher Scientific completed an Olink Explore HT proteomic analysis of approximately 5,500 research samples from the Michael J. Fox Foundation’s (MJFF) landmark study,...

more new items

CDMOs Expand and Build for Future Growth

The top contract development and manufacturing organizations (CDMOs) have been busy in recent months expanding their service offerings, building new facilities, and navigating how...

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished...

Thermo and Michael J. Fox Foundation Collaborate to Advance Proteomics-Enabled Parkinson’s...

Thermo Fisher Scientific completed an Olink Explore HT proteomic analysis of approximately 5,500 research samples from the Michael J. Fox Foundation’s (MJFF) landmark study,...